In this large observational study, patients with MBC diagnosed at a very young age ( ≤35 years) experienced shorter OS compared to those diagnosed in middle-age, especially when comparing individuals with HER2−, luminal B-like metastatic tumors. The gene discussed is ERBB2; the disease is metastatic neoplasm.